A most exuberant day in the market and SNDK and GOG red! Also, just got rid of my ELOS here for .32. Not willing to hold on into the earnings after the debacle with VPHM.
Amgen-AMGN possible impact from AMGN vs. Roche hearing@SBSH
Oral arguments of Rochs's request for a dismissal of AMGN's EPO patent infringement complaint are expected to begin on 5/10 at 2pm EST. The firm says its possible for the Judge to issue a decision at the hearing. If he rules in favor of Roche, the firm sees downside in AMGN shares limited to 1-2 points. If the Judge rules to proceed with the case or to pursue AMGN's request of discovery jurisdiction, the analyst believes shares could move up 5-10%. AMGN shares are Buy rated. For the latest breaking news, listen to Fly Radio
Market Data 
Markets 
AI
